CN105441496A - Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation - Google Patents

Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation Download PDF

Info

Publication number
CN105441496A
CN105441496A CN201510967655.0A CN201510967655A CN105441496A CN 105441496 A CN105441496 A CN 105441496A CN 201510967655 A CN201510967655 A CN 201510967655A CN 105441496 A CN105441496 A CN 105441496A
Authority
CN
China
Prior art keywords
cadaverine
gene
site
glucose
lyse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510967655.0A
Other languages
Chinese (zh)
Inventor
黎明
路福平
唐奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University of Science and Technology
Original Assignee
Tianjin University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University of Science and Technology filed Critical Tianjin University of Science and Technology
Priority to CN201510967655.0A priority Critical patent/CN105441496A/en
Publication of CN105441496A publication Critical patent/CN105441496A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/77Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • C12N9/92Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01018Lysine decarboxylase (4.1.1.18)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01009Glucose-6-phosphate isomerase (5.3.1.9)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation. According to the method, key regulation and control sites in a metabolic pathway for synthesizing cadaverine through microorganisms are modified, and preferably, the key regulation and control sites are lysine transport protein gene lysE site and/or D-glucose-6-phosphateketol-isomerase gene pgi site, or the key regulation and control sites are regulation and control sites for regulating and controlling expression of the above genes. The modification method for the regulation and control sites comprises deleting lysine transport protein gene lysE and/or D-glucose-6-phosphateketol-isomerase gene pgi, or weakening expression or enzyme activity of lysine transport protein gene lysE and/or D-glucose-6-phosphateketol-isomerase gene pgi, and therefore the yield of cadaverine is effectively improved, saccharides utilization rate is increased, and production cost is reduced.

Description

A kind ofly improve microorganism and utilize carbohydrate fermentation to produce the method for cadaverine
Technical field
The invention belongs to genetic engineering bacterium technical field, transform especially by the key regulatory site utilizing carbohydrate fermentation to synthesize in the pathways metabolism of cadaverine microorganism, thus effectively a kind of of output of raising cadaverine improves the method that microorganism utilizes carbohydrate fermentation production cadaverine.
Background technology
Cadaverine (Cadaverine) is a polyamine species, namely 1,5-pentamethylene diamine (abbreviation pentamethylene diamine), is generated by Methionin decarboxylation in vivo, be extensively be present in, in organism, there is bioactive nitrogenous base, but be also present in septic matter as a kind of ptomaine.Cadaverine is the important source material of synthesizing new material polymeric amide-54 (being formed by cadaverine and succsinic acid condensation) and polymeric amide-56 (being formed by cadaverine and oxalic acid condensation), has important industrial use.
The method of current synthesis cadaverine has chemical synthesis and enzyme transforming process.Chemical synthesis condition is harsh, contaminate environment, and enzyme transforming process process is complicated, cost is higher.Utilizing genetic engineering technique to construct metabolic engineering bacteria, directly necessary for human product is prepared in mass-producing is most economical, environmental protection and the most promising method, is direction and the focus of metabolic engineering research.
Production by Microorganism Fermentation cadaverine is exactly that microorganism utilizes carbohydrate to ferment, and directly synthesizes cadaverine in a large number by metabolism, this method is simple, economy, environmental protection and efficient.Although intestinal bacteria, corpse bacillus, hafnia alvei etc. directly can synthesize cadaverine, also carried out extensive research to cadaverine synthesis adjustment, the output of cadaverine has much room for improvement.
JP2002223770 and some papers show to improve cadaverine produce by lysine decarboxylase gene and/or Methionin-cadaverine antiporter gene cadB being incorporated into Corynebacterium glutamicum or intestinal bacteria.CN200780006903.9 discloses knocking out, suppress or strengthening of series of genes in cadaverine route of synthesis, but these documents and patent all do not find to knock out or weaken the output that Methionin transporter gene lysE and glucose-6-phosphate isomerase gene pgi effectively can improve cadaverine.
Therefore, by contrast, there are the different of essence in patent application of the present invention and above-mentioned open source literature.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art part, there is provided a kind of by finding the new regulatory site that can improve fermentable carbohydrate production cadaverine, and the phraseology changing these locus genes improves to improve a kind of of cadaverine output the method that microorganism utilizes carbohydrate fermentation production cadaverine.
To achieve these goals, the technical solution adopted in the present invention is as follows:
Improving microorganism utilizes carbohydrate fermentation to produce a method for cadaverine, is transformed by the key regulatory site in the pathways metabolism to Microbe synthesis cadaverine.
And described key regulatory site is Methionin transporter gene lysE site and glucose-6-phosphate isomerase gene pgi site, or regulate and control the regulatory site of these two genes that above-mentioned key regulatory locus gene is expressed.
And, knock out Methionin transporter gene lysE and/or glucose-6-phosphate isomerase gene pgi, and/or, by changing their promotor, ribosome bind site or carrying out transgenation and weaken their expression or the activity of weakening enzyme.
And described microorganism is intestinal bacteria, Corynebacterium glutamicum, honeycomb Hough Buddhist nun or their recombinant bacterial strain.
And the concrete steps of transformation are as follows:
By enterobacteria lysine decarboxylase gene cadA is cloned on the PCK gene pepck site of Corynebacterium glutamicum, builds and produce cadaverine Corynebacterium glutamicum recombinant bacterium CAD1;
The Methionin transporter gene lysE of recombinant bacterial strain CAD1 is knocked out, constructs the Corynebacterium glutamicum recombinant bacterium CAD2 of cadaverine output increased;
The glucose-6-phosphate isomerase gene pgi of recombinant bacterial strain CAD2 is knocked out, constructs the Corynebacterium glutamicum recombinant bacterium CAD3 of cadaverine output increased.
The advantage that the present invention obtains and positively effect:
1, present method is transformed by utilizing the pathways metabolism of carbohydrate fermentation synthesis cadaverine to microorganism, the microorganism being produced cadaverine by transformation utilizes carbohydrate fermentation to produce the regulatory site of cadaverine, these regulatory sites comprise Methionin transporter gene lysE and glucose-6-phosphate isomerase gene pgi, by knocking out and/or weaken Methionin transporter gene lysE and glucose-6-phosphate isomerase gene pgi, effectively can improve the output of cadaverine, thus improve the utilization ratio of carbohydrate, reduce production cost.
2, Methionin transporter gene lysE knocks out and Methionin-pentamethylene diamine antiporter gene cadB is integrated into lysE gene locus, stops their expression by present method, suppresses the secretion of Methionin, accelerates pentamethylene diamine to be transported to outside born of the same parents simultaneously; Acetyl transferase gene Ncgl1469 is pounded out the degraded that can prevent cadaverine; Glucose-6-phosphate isomerase gene pgi is knocked out, cuts off glycometabolic glycolytic pathway, thus effectively improve the output of cadaverine.
Accompanying drawing explanation
Fig. 1 is the Yield mapping of different recombinant bacterial strain cadaverine in the present invention.
Embodiment
Below in conjunction with embodiment, the present invention is further described, and following embodiment is illustrative, is not determinate, can not limit protection scope of the present invention with following embodiment.
The method used in the present invention, if no special instructions, is the ordinary method in this area; The reagent used in the present invention, if no special instructions, is the common agents in this area.
The implication of technical term involved in the present invention:
" cadaverine " be i.e. 1,5-pentamethylene diamine.
" recombinant bacterial strain " refers to non-wild type strain, comprises the non-wild type strain obtained by selection by mutation, genetic engineering breeding or other any method.
" regulatory site " refers to other gene and the position thereof of Methionin transporter gene lysE and glucose-6-phosphate isomerase gene pgi and position and all these genetic expressions of regulation and control.
" gene knockout " to refer to knock out or suddenly change the regulatory gene of goal gene, the ribosome bind site of goal gene, the promotor of goal gene or goal gene, goal gene can not be expressed or can not be expressed as activated protein (enzyme).
" gene reduction " refers to that the expression level of goal gene or enzymic activity are lower than microorganism expression level before operation or enzymic activity.Comprise the promotor by changing them, ribosome bind site or carry out transgenation and other any method weakens their expression or the activity of weakening enzyme.
The technique means that the present invention uses:
It is all disclosed sequence that gene order of the present invention comprises lysine decarboxylase gene, Methionin-cadaverine albumen antiport gene, Methionin transporter gene lysE and glucose-6-phosphate isomerase gene pgi sequence.The detection etc. of plasmid pK18mobsacB, molecule manipulation technology, microbial culture technique and cadaverine is all known for a person skilled in the art.
Embodiment 1
A kind ofly improve microorganism and utilize carbohydrate fermentation to produce the method for cadaverine, key regulatory site for Microbe synthesis cadaverine in described method is transformed, such as, described key regulatory site is Methionin transporter gene lysE site and/or glucose-6-phosphate isomerase gene pgi site, or described key regulatory site is the regulatory site that regulation and control said gene is expressed.
More preferably, the described key regulatory site for Microbe synthesis cadaverine transform as: knock out Methionin transporter gene lysE and/or glucose-6-phosphate isomerase gene pgi, and/or, by changing their promotor, ribosome bind site or carrying out transgenation and weaken their expression or the activity of weakening enzyme.
More preferably, described microorganism is intestinal bacteria, Corynebacterium glutamicum, honeycomb Hough Buddhist nun or their recombinant bacterial strain.
Above-mentioned raising microorganism utilizes carbohydrate fermentation to produce the method for cadaverine, and concrete steps are as follows:
(1) produce the structure of cadaverine Corynebacterium glutamicum recombinant bacterium CAD1
Primers near the intestinal bacteria lysine decarboxylase gene cadA provided according to NCBI and PCK gene pepck, amplify the upper of cadA and PCK gene pepck respectively, downstream homology arm sequence pckL and pckR, then with cadA, pckL and pckR is template, by Overlap extension PCR, these three fragments are linked into pckL-cadA-pckR fragment, this fragment by HindIII and BamHI enzyme cut rear clone to pK18mobsacB identical restriction enzyme site between, construct plasmid pK18-pckL-cadA-pckR.With this Plastid transformation Corynebacterium glutamicum C.glutamicumATCC13032, and filter out positive colony by bacterium colony PCR.The positive colony filtered out is inoculated into sucrose plate (the LB substratum of 10% sucrose), is inoculated into respectively after growing bacterium colony containing kantlex with not containing on the LB flat board of kantlex.LB flat board containing kantlex does not grow and the bacterium colony of LB grow on plates not containing kantlex is the recombinant bacterial strain that possible cadA gene is inserted into pepck gene locus, and then carry out bacterium colony PCR checking, if amplify the band of object clip size, be and produce cadaverine Corynebacterium glutamicum recombinant bacterium CAD1.
Primer sequence designed by structure recombinant bacterium CAD1 is as table 1:
Table 1 builds primer table needed for recombinant bacterium CAD1 for the present invention
(2) knock out the structure of the Corynebacterium glutamicum recombinant bacterium CAD2 of Methionin transporter gene lysE
Primers near the Methionin-cadaverine antiporter gene cadB provided according to NCBI and Methionin transporter gene lysE, amplify the upper of cadB and Methionin transporter gene lysE respectively, downstream homology arm sequence lysEL and lysER, then with cadB, lysEL and lysER is template, by Overlap extension PCR, these three fragments are linked into lysEL-cadB-lysER fragment, this fragment by HindIII and BamHI enzyme cut rear clone to pK18mobsacB identical restriction enzyme site between, obtain pK18-lysEL-cadB-lysER carrier, with this vector to product cadaverine Corynebacterium glutamicum recombinant bacterium CAD1, adopt screening method above, obtain the product cadaverine Corynebacterium glutamicum recombinant bacterium CAD2 that lysE gene is knocked.
Primer sequence designed by structure recombinant bacterium CAD2 is as table 2:
Table 2 is for building primer table needed for recombinant bacterium CAD2
(3) knock out the structure of the Corynebacterium glutamicum recombinant bacterium CAD3 of glucose-6-phosphate isomerase gene pgi
According to the primers of the glucose-6-phosphate isomerase gene pgi that NCBI provides, amplify the upper of glucose-6-phosphate isomerase gene pgi respectively, downstream homology arm sequence pgiL and pgiR, then with pgiL and pgiR for template, by Overlap extension PCR, these two fragments are linked into pgiL-pgiR fragment, this fragment by HindIII and BamHI enzyme cut rear clone to pK18mobsacB identical restriction enzyme site between, obtain pK18-pgiL-pgiR carrier, with the product cadaverine Corynebacterium glutamicum recombinant bacterium CAD2 that this vector is pounded out to lysE gene, adopt screening method above, obtain the product cadaverine Corynebacterium glutamicum recombinant bacterium CAD3 that lysE and pgi gene is all knocked.
Primer sequence designed by structure recombinant bacterium CAD3 is as table 3:
Table 3: build primer needed for recombinant bacterium CAD3
(4) the shake flask fermentation of recombinant bacterial strain CAD1, CAD2 and CAD3 and the mensuration of cadaverine output
On flat board, picking one ring mono-clonal recombinant bacterial strain is inoculated into containing 5mLLBG seed culture medium (containing the LB substratum of 0.5% glucose, above-mentioned percentage ratio is quality percent by volume g/mL) middle cultivation 14-16h, inoculum size with 2% is linked into and 50mL fermention medium (glucose 5%, (NH is housed 4) 2sO 43%, yeast powder 0.5%, K 2hPO 42.5g/L, MgSO 47H 2o0.75g/L, CaCl 22H 2o50mg/L, FeSO 47H 2o50mg/L, above-mentioned percentage ratio is quality percent by volume g/mL) 250mL triangular flask in, 30 DEG C, 200r/min cultivates 36h.The centrifugal 5min of fermented liquid 12000r/min, gets supernatant liquor 4 DEG C preservation, obtains the fermented supernatant fluid containing cadaverine.
Get 1mL fermented supernatant fluid to add in 5mL tool plug scale test tube, add 500 μ L2mol/LNaOH solution, 10 μ L Benzoyl chlorides, 37 DEG C of water-bath jolting 20min, every 5min vortex vibration 30s, add 0.5gNaCl, 1mL ether vibration 30s stratification.Upper strata ether is taken in another centrifuge tube, treats ether volatilization completely, add 500 μ L dissolve with methanol, as HPLC detection sample after mistake film.Column temperature: 20 DEG C; Moving phase: 100% acetonitrile, 0.02mol/L ammonium acetate; Gradient: 0 ~ 5min acetonitrile volume fraction is 30%, 5 ~ 10min acetonitrile volume fraction be 75%, 10 ~ 15min acetonitrile volume fraction is 30%.Meanwhile, get different concns cadaverine standard substance working solution and carry out same process, and formulate typical curve.According to the content of the cadaverine in the different sample of standard curve determination.Each sample does three repetitions, asks the mean value of cadaverine output.Result is as Fig. 1.
As can be seen from Figure 1, after knocking out lysE and/or pgi gene, cadaverine output significantly improves, and wherein recombinant bacterial strain CAD2 is than the cadaverine output increased about 77.43% of CAD1; Recombinant bacterial strain CAD3, than the cadaverine output increased about 304.87% of CAD1, than the cadaverine output increased about 128.18% of CAD2, illustrates that lysE and pgi gene is the critical sites regulating cadaverine output, knocks out the output that cadaverine effectively can be improved in these sites.
Embodiment 2
Improving microorganism utilizes carbohydrate fermentation to produce a method for cadaverine, is transformed by the key regulatory site in the pathways metabolism to Microbe synthesis cadaverine.
More preferably, described key regulatory site is Methionin transporter gene lysE site and glucose-6-phosphate isomerase gene pgi site, or regulates and controls the regulatory site of these two genes that above-mentioned key regulatory locus gene is expressed.
More preferably, describedly to transform as: knock out Methionin transporter gene lysE and/or glucose-6-phosphate isomerase gene pgi, and/or, by changing their promotor, ribosome bind site or carrying out transgenation and weaken their expression or the activity of weakening enzyme.
More preferably, described microorganism is intestinal bacteria, Corynebacterium glutamicum, honeycomb Hough Buddhist nun or their recombinant bacterial strain.
The concrete steps of transformation are as follows:
By being cloned on the PCK gene pepck site of Corynebacterium glutamicum by enterobacteria lysine decarboxylase gene cadA, build and produce cadaverine Corynebacterium glutamicum recombinant bacterium CAD1, cadaverine output is 2.26g/L.
Knocked out by the Methionin transporter gene lysE of recombinant bacterial strain CAD1, construct the Corynebacterium glutamicum recombinant bacterium CAD2 of cadaverine output increased, its cadaverine output is 4.01g/L, improves 77.43% than CAD1.
Knocked out by the glucose-6-phosphate isomerase gene pgi of recombinant bacterial strain CAD2, construct the Corynebacterium glutamicum recombinant bacterium CAD3 of cadaverine output increased, its cadaverine output is 9.15g/L.Recombinant bacterial strain CAD3 than the cadaverine output increased about 304.87% of CAD1, than the cadaverine output increased about 128.18% of CAD2.

Claims (5)

1. improving microorganism utilizes carbohydrate fermentation to produce a method for cadaverine, it is characterized in that: transformed by the key regulatory site in the pathways metabolism to Microbe synthesis cadaverine.
2. raising microorganism according to claim 1 utilizes carbohydrate fermentation to produce the method for cadaverine, it is characterized in that: described key regulatory site is Methionin transporter gene lysE site and glucose-6-phosphate isomerase gene pgi site, or regulate and control the regulatory site of these two genes that above-mentioned key regulatory locus gene is expressed.
3. raising microorganism according to claim 1 utilizes carbohydrate fermentation to produce the method for cadaverine, it is characterized in that: described in transform as: knock out Methionin transporter gene lysE and/or glucose-6-phosphate isomerase gene pgi, and/or, by changing their promotor, ribosome bind site or carrying out transgenation and weaken their expression or the activity of weakening enzyme.
4. the raising microorganism according to any one of claims 1 to 3 utilizes carbohydrate fermentation to produce the method for cadaverine, it is characterized in that: described microorganism is intestinal bacteria, Corynebacterium glutamicum, honeycomb Hough Buddhist nun or their recombinant bacterial strain.
5. the raising microorganism according to any one of claims 1 to 3 utilizes carbohydrate fermentation to produce the method for cadaverine, it is characterized in that: the concrete steps of transformation are as follows:
By enterobacteria lysine decarboxylase gene cadA is cloned on the PCK gene pepck site of Corynebacterium glutamicum, builds and produce cadaverine Corynebacterium glutamicum recombinant bacterium CAD1;
The Methionin transporter gene lysE of recombinant bacterial strain CAD1 is knocked out, constructs the Corynebacterium glutamicum recombinant bacterium CAD2 of cadaverine output increased;
The glucose-6-phosphate isomerase gene pgi of recombinant bacterial strain CAD2 is knocked out, constructs the Corynebacterium glutamicum recombinant bacterium CAD3 of cadaverine output increased.
CN201510967655.0A 2015-12-22 2015-12-22 Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation Pending CN105441496A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510967655.0A CN105441496A (en) 2015-12-22 2015-12-22 Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510967655.0A CN105441496A (en) 2015-12-22 2015-12-22 Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation

Publications (1)

Publication Number Publication Date
CN105441496A true CN105441496A (en) 2016-03-30

Family

ID=55552125

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510967655.0A Pending CN105441496A (en) 2015-12-22 2015-12-22 Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation

Country Status (1)

Country Link
CN (1) CN105441496A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108441507A (en) * 2018-04-13 2018-08-24 绿康生化股份有限公司 Pass through the method and bacterial strain of the knockout gene constructed bacillus licheniformis of lysE and its application
CN114317511A (en) * 2022-03-10 2022-04-12 北京爱普益医学检验中心有限公司 Protein, gene, recombinant vector, expression cassette, host and application

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102124119A (en) * 2008-04-30 2011-07-13 巴斯夫欧洲公司 Production process for fine chemicals using microorganisms with reduced isocitrate dehydrogenase activity
CN102753682A (en) * 2009-12-17 2012-10-24 巴斯夫欧洲公司 Processes and recombinant microorganisms for the production of cadaverine
CN102851307A (en) * 2012-05-02 2013-01-02 上海凯赛生物技术研发中心有限公司 Recombinant expression plasmid vector stable in Hafnia alvei, and application thereof
WO2013093737A1 (en) * 2011-12-22 2013-06-27 Basf Se Processes and recombinant microorganisms for the production of fine chemicals
CN103492553A (en) * 2011-02-22 2014-01-01 巴斯夫欧洲公司 Processes and recombinant microorganisms for the production of cadaverine
CN104254606A (en) * 2012-01-11 2014-12-31 韩国科学技术院 Novel synthesis-regulating srna and method for preparing same
CN104498519A (en) * 2014-12-19 2015-04-08 南京工业大学 Recombinant expression vector and application thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102124119A (en) * 2008-04-30 2011-07-13 巴斯夫欧洲公司 Production process for fine chemicals using microorganisms with reduced isocitrate dehydrogenase activity
CN102753682A (en) * 2009-12-17 2012-10-24 巴斯夫欧洲公司 Processes and recombinant microorganisms for the production of cadaverine
CN103492553A (en) * 2011-02-22 2014-01-01 巴斯夫欧洲公司 Processes and recombinant microorganisms for the production of cadaverine
WO2013093737A1 (en) * 2011-12-22 2013-06-27 Basf Se Processes and recombinant microorganisms for the production of fine chemicals
CN104254606A (en) * 2012-01-11 2014-12-31 韩国科学技术院 Novel synthesis-regulating srna and method for preparing same
CN102851307A (en) * 2012-05-02 2013-01-02 上海凯赛生物技术研发中心有限公司 Recombinant expression plasmid vector stable in Hafnia alvei, and application thereof
CN104498519A (en) * 2014-12-19 2015-04-08 南京工业大学 Recombinant expression vector and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
徐晓利 等: "《医学生物化学》", 31 October 1998, 人民卫生出版社 *
黎明 等: "谷氨酸棒杆菌发酵生产1,5-戊二胺的代谢流分析", 《天津科技大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108441507A (en) * 2018-04-13 2018-08-24 绿康生化股份有限公司 Pass through the method and bacterial strain of the knockout gene constructed bacillus licheniformis of lysE and its application
CN114317511A (en) * 2022-03-10 2022-04-12 北京爱普益医学检验中心有限公司 Protein, gene, recombinant vector, expression cassette, host and application

Similar Documents

Publication Publication Date Title
CN101831414B (en) Process for extracellularly producing recombinant alpha-cyclodextrin glucosyltransferase
Wang et al. High-level succinic acid production and yield by lactose-induced expression of phosphoenolpyruvate carboxylase in ptsG mutant Escherichia coli
Bandyopadhyay et al. Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics
CN108456652B (en) Sphingosine monad gene engineering bacterium and construction method and application thereof
CN104974974A (en) Saccharopolyspora spinosa high-pleocidin-yield engineering strain and application thereof
US10233439B2 (en) Directed modification of glucosamine synthase mutant and application thereof
CN105441496A (en) Method for improving yield of cadaverine produced by utilizing microorganisms for saccharides fermentation
CN106995794A (en) A kind of Actinobacillus succinogenes engineered strain and its construction method and purposes for improving succinic acid yield
Liu et al. Feeding strategies for the enhanced production of α-arbutin in the fed-batch fermentation of Xanthomonas maltophilia BT-112
CN110950938B (en) Bi-component regulation and control system and application thereof in preparing vitamin B12In (1)
CN105969712B (en) A method of coexpression molecular chaperone protein improves recombination bacillus coli 1,2,4- butantriol yield
CN106148378A (en) Improve yield of erythrocin by sugared many spores red mould SACE_Lrp gene approach
CN104152483A (en) Application of argJ gene in fermentation production of L-citrulline
CN116751731A (en) Fermentation process for large-scale plasmid production
Zhang et al. Improved production of the tallysomycin H-1 in Streptoalloteichus hindustanus SB8005 strain by fermentation optimization
CN109136253A (en) Method for improving yield of erythromycin through saccharopolyspora erythraea SACE _5754 gene approach
CN107446944B (en) Method for improving carbon source utilization rate and transformation efficiency of erythromycin producing strain so as to improve erythromycin synthesis efficiency
CN111041020B (en) Isocitrate lyase mutant, mutant gene and application thereof in preparation of vitamin B12In (1)
CN111748564B (en) Genetically modified violacein biosynthetic gene cluster, recombinant expression vector, engineering bacterium and application thereof
Wang et al. Enhanced natamycin production by co-expression of Vitreoscilla hemoglobin and antibiotic positive regulators in Streptomyces gilvosporeus
Feng et al. Effect of temperature on synthesis of clavulanic acid and impurity substance G during fermentation by Streptomyces clavuligerus
CN106520821B (en) Suitable for the t7 rna polymerase expression cassette PhT7 and its expression vector of streptomycete and application
CN107245471A (en) It is a kind of to recombinate streptomyces hygroscopicus and its application in jinggangmycin A yield is improved
Li et al. Enhancement of production of d-Glucosamine in Escherichia coli by blocking three pathways involved in the consumption of GlcN and GlcNAc
CN112359007A (en) Exogenous introduction edd gene bacillus licheniformis for producing bacitracin and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160330